Related Experiment Videos
Cost-benefit aspects of post-myocardial infarction intervention
Insights
Following myocardial infarction, mortality risk decreases over time. Key interventions like beta-blockade and smoking cessation significantly reduce post-heart attack deaths, improving long-term cardiac patient survival.
Area of Science:
- Cardiology
- Public Health
Background:
- Mortality after myocardial infarction (MI) is high, particularly in the first year post-hospitalization.
- While mortality risk declines in the second year, non-fatal recurrences remain a concern.
- Prognostic models can predict mortality, with myocardial damage size being a key secondary risk factor.
Purpose of the Study:
- To analyze mortality and non-fatal recurrence rates after myocardial infarction.
- To identify key risk factors influencing short-term and long-term prognosis.
- To evaluate the effectiveness of preventive strategies.
Main Methods:
- Analysis of post-myocardial infarction patient data.
- Utilized prognostic models to predict mortality.
- Reviewed evidence for preventive interventions such as beta-blockade, smoking cessation, and surgery.
Main Results:
- Mortality risk decreases from 10% in the first year to 5% in the second year post-MI.
- Myocardial damage size is a significant predictor of early mortality, but not non-fatal recurrences.
- Cardiovascular deaths constitute 90% of early deaths post-MI.
- Chronic beta-blockade and smoking cessation can potentially halve total mortality.
Conclusions:
- Short-term prognosis post-MI is linked to myocardial damage, suggesting interventions targeting arrhythmias.
- Long-term prognosis is influenced by primary risk factors, emphasizing vascular health.
- Beta-blockade and smoking cessation are highly effective preventive measures, significantly reducing mortality.
- The impact of coronary surgery, lipid-lowering, and blood pressure reduction requires further assessment.
Abstract:
After myocardial infarction the mortality during the first post hospital year declines from approximately 10 per cent to 5 per cent during the second year. The rates of non-fatal recurrencies are similar. Mortality is related to age but not to the same extent to sex. Non-fatal recurrencies are, however, not related to age. Prediction of mortality is feasible by several prognostic models. Factors related to size of myocardial damage stand out as the important secondary risk factors for the years immediately after infarction. Most of these factors are not generally related to risk of non-fatal recurrencies. The proportion of cardiovascular deaths is 90 per cent during the first years and declines thereafter. Simplistically it may be said that the prognosis during the first years is related to the extent of the myocardial damage and thereafter primary risk factors become more important. Thus, it seems logical in the short-term perspective to influence myocardial factors and related arrhythmias and in the long-term perspective to influence primary risk factors which more likely operate on the vascular factors. Three preventive methods have demonstrated a positive benefit: 1) chronic beta-blockade, 2) cessation of smoking, 3) by-pass surgery in certain categories. After careful calculations it may be argued that at least half of the total mortality may be inhibited by beta-blockade and cessation of smoking. The impact of coronary surgery, lipid lowering and reduction of high blood pressures is more difficult to assess.